Evidence map›Paper›PMID 42621067›Full record

ArticleIBRO neuroscience reports2026

Retraction notice to "Selective mapping of Brain COX-1 with [11 C]PS13: Pharmacokinetic evidence from human PET imaging" [IBRO Neurosci. Rep. 18 (2025) 657-662].

Kiana Orangi, Kimiya Batebi, Farnoosh Vosough, Mahdiyeh Nozad Varjovi, Fatemeh Salehian, Sahar Mesbah, Mehrnaz Salahi, Sajjad Hajihosseini, Mohammad Yousef Fazel, Saman Zaman and 4 more

Abstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in IBRO neuroscience reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Kiana OrangiFaculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Kimiya BatebiDoctor of Pharmacy (Pharm.D.), School of Pharmacy, Islamic Azad University of Medical Sciences, Tehran, Iran.
Farnoosh VosoughStudent Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mahdiyeh Nozad VarjoviStudent Research Committee, School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Fatemeh SalehianStudent Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Sahar MesbahStudent Research Committee, Faculty of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Mehrnaz SalahiNovel Drug Delivery Systems Research Centre, Department of Pharmaceutics, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
Sajjad HajihosseiniStudent Research Committee, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Yousef FazelSchool of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Saman ZamanAhvaz Jondishapur University of Medical Sciences, Ahvaz, Iran.
Reza Hossein ZadehStudent Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Tehran, Iran.
Alaleh AlizadehStudents Research Committee, Faculty of Medicine, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
Mahsa Asadi AnarCollege of Medicine, University of Arizona, Tucson, AZ, USA.
Niloofar DeraviStudent Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This retracts the article DOI: 10.1016/j.ibneur.2025.04.012.].

Identifiers

PMID42621067
PMCPMC13486316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.